Structures by: Sridhar B.
Total: 368
5'-(4-Bromophenyl)-1,1''-dimethyl-4'-phenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione
C32H25BrN2O3
Acta Crystallographica Section C (2015) 71, 8
a=9.0986(7)Å b=9.7185(7)Å c=16.5056(13)Å
α=78.9150(10)° β=75.7630(10)° γ=67.6870(10)°
<i>tert</i>-Butyl 1''-methyl-2,2''-dioxo-4'-phenyl-5'-(<i>p</i>-tolyl)-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-1-carboxylate
C37H34N2O5
Acta Crystallographica Section C (2015) 71, 8
a=10.1226(9)Å b=14.3682(13)Å c=21.353(2)Å
α=90° β=91.799(2)° γ=90°
Methyl 3a-acetyl-3-(4-bromophenyl)-4-oxo-1-phenyl-3,3a,4,9b-tetrahydro-1<i>H</i>-furo[3,4-<i>c</i>]chromene-1-carboxylate benzene monosolvate
C27H21BrO6,C6H6
Acta Crystallographica Section C (2017) 73, 5 407-413
a=8.4269(6)Å b=12.4905(8)Å c=15.1415(10)Å
α=66.5300(10)° β=76.0050(10)° γ=85.4730(10)°
Methyl 3a-acetyl-3-(4-bromophenyl)-4-oxo-1-phenyl-3,3a,4,9b-tetrahydro-1<i>H</i>-furo[3,4-<i>c</i>]chromene-1-carboxylate toluene monosolvate
C27H21BrO6,C7H8
Acta Crystallographica Section C (2017) 73, 5 407-413
a=8.3989(5)Å b=12.5415(7)Å c=15.2195(8)Å
α=67.4080(10)° β=76.1350(10)° γ=85.4580(10)°
Β-Resorcylic acid monohydrate
C7H6O4,H2O
Acta Crystallographica Section C (2015) 71, 12
a=3.8229(15)Å b=8.972(3)Å c=11.645(4)Å
α=75.011(6)° β=89.036(6)° γ=81.735(6)°
Thymine—–β-resorcylic acid—–water (1/1/1)
C5H6N2O2,C7H6O4,H2O
Acta Crystallographica Section C (2015) 71, 12
a=26.534(2)Å b=6.5377(6)Å c=7.6136(7)Å
α=90° β=90° γ=90°
1,1''-Dibenzyl-5'-(4-chlorophenyl)-4'-phenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione
C44H33ClN2O3
Acta Crystallographica Section C (2015) 71, 11
a=10.1099(10)Å b=11.3367(11)Å c=17.0315(17)Å
α=74.755(2)° β=78.503(2)° γ=65.557(2)°
1''-Acetyl-1-benzyl-5'-(4-chlorophenyl)-4'-phenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione
C39H29ClN2O4
Acta Crystallographica Section C (2015) 71, 11
a=11.9830(5)Å b=12.9260(6)Å c=21.5664(10)Å
α=76.3300(10)° β=76.5220(10)° γ=77.5530(10)°
1''-Acetyl-1-benzyl-4',5'-diphenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione
C39H30N2O4
Acta Crystallographica Section C (2015) 71, 11
a=9.7565(10)Å b=16.6868(16)Å c=19.9593(19)Å
α=71.653(2)° β=81.657(2)° γ=89.314(2)°
1''-Acetyl-1-benzyl-4',5'-diphenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione acetonitrile hemisolvate
C39H30N2O4,0.5(C2H3N)
Acta Crystallographica Section C (2015) 71, 11
a=9.6940(5)Å b=18.5810(10)Å c=20.1552(11)Å
α=114.872(2)° β=98.465(2)° γ=99.397(2)°
Thymine--pyrogallol (1/2)
C5H6N2O2,2(C6H6O3)
Acta Crystallographica Section C Structural Chemistry (2015) 71, 7 602
a=6.9652(13)Å b=10.2125(19)Å c=12.951(2)Å
α=97.218(3)° β=99.189(3)° γ=108.549(3)°
Thymine--hydroquinone (2/1)
2(C5H6N2O2),C6H6O2
Acta Crystallographica Section C Structural Chemistry (2015) 71, 7 602
a=14.204(3)Å b=6.9634(13)Å c=8.4505(15)Å
α=90° β=97.639(3)° γ=90°
Thymine--catechol (2/1)
2(C5H6N2O2),C6H6O2
Acta Crystallographica Section C Structural Chemistry (2015) 71, 7 602
a=6.9499(7)Å b=9.0237(10)Å c=26.828(3)Å
α=90° β=90° γ=90°
Thymine--catechol (1/1)
C5H6N2O2,C6H6O2
Acta Crystallographica Section C Structural Chemistry (2015) 71, 7 602
a=6.9132(8)Å b=8.9917(10)Å c=36.898(4)Å
α=90° β=90° γ=90°
Methyl 3a-acetyl-3-(4-bromophenyl)-4-oxo-1-phenyl-3,3a,4,9b-tetrahydro-1<i>H</i>-furo[3,4-<i>c</i>]chromene-1-carboxylate xylene monosolvate
C27H21BrO6,C8H10
Acta Crystallographica Section C (2017) 73, 5 407-413
a=8.2587(6)Å b=12.7841(9)Å c=15.6238(11)Å
α=66.4460(10)° β=76.6340(10)° γ=86.0300(10)°
9-Butyl-3-(9-butyl-9<i>H</i>-carbazol-3-yl)-9<i>H</i>-carbazole
C32H32N2
Acta Crystallographica Section E (2014) 70, 12 o1283-o1284
a=5.6184(4)Å b=11.0946(7)Å c=19.4673(13)Å
α=90° β=95.9820(10)° γ=90°
4-Amino-1-(4-methylbenzyl)pyridinium bromide
C13H15N2,Br
Acta Crystallographica Section E (2014) 70, 12 o1293-o1294
a=10.5646(6)Å b=18.7980(11)Å c=26.9782(16)Å
α=90° β=90° γ=90°
1-(2,4-Dimethylphenyl)urea
C9H12N2O
Acta Crystallographica Section E (2015) 71, 1 o60-o61
a=14.631(4)Å b=7.0633(19)Å c=8.786(2)Å
α=90° β=93.530(4)° γ=90°
2'-[(2',4'-Difluorobiphenyl-4-yl)carbonyl]-1'-phenyl-1',2',5',6',7',7a'-hexahydrospiro[indole-3,3'-pyrrolizin]-2(1<i>H</i>)-one
C33H26F2N2O2
Acta Crystallographica Section E (2015) 71, 8 915-918
a=12.6019(13)Å b=9.3128(10)Å c=22.441(2)Å
α=90° β=98.805(2)° γ=90°
Methyl (2<i>Z</i>)-3-(4-chlorophenyl)-2-[(3-methyl-1<i>H</i>-indol-1-yl)methyl]prop-2-enoate
C20H18ClNO2
Acta Crystallographica Section E (2015) 71, 6 720-722
a=9.5867(5)Å b=15.9077(8)Å c=10.8902(6)Å
α=90° β=94.7870(10)° γ=90°
Oxyclozanide benzene hemisolvate
C13H6Cl5NO3,0.5(C6H6)
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1056-1063
a=7.16810(8)Å b=9.28821(10)Å c=13.42132(15)Å
α=88.3124(5)° β=85.6481(5)° γ=69.7508(5)°
Oxyclozanide xylene hemisolvate
C13H6Cl5NO3,0.5(C8H10)
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1056-1063
a=7.12429(8)Å b=9.40484(11)Å c=14.27988(16)Å
α=83.7014(5)° β=80.0916(5)° γ=67.8388(4)°
Oxyclozanide toluene hemisolvate
C13H6Cl5NO3,0.5(C7H8)
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1056-1063
a=6.92017(8)Å b=9.71946(11)Å c=13.98498(17)Å
α=86.3845(5)° β=85.4687(5)° γ=65.8069(5)°
Oxyclozanide chlorobenzene hemisolvate
C13H6Cl5NO3,0.5(C6H5Cl)
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1056-1063
a=6.90927(8)Å b=9.69846(10)Å c=13.97198(15)Å
α=86.5557(5)° β=85.9678(5)° γ=65.8305(5)°
DL-valine DL-valinium picrate
C5H12NO2,C6H2N3O7,C5H11NO2
Acta Crystallographica Section E (2004) 60, 10 o1722-o1724
a=5.3822(4)Å b=23.221(2)Å c=16.579(2)Å
α=90.00° β=94.695(7)° γ=90.00°
N-{3-(4-methylphenyl)-6-[(Z)-(4-methylphenyl)methylidene]-2-phenyl- 2-azabicyclo[2.2.2]oct-5-ylidene}aniline
C34H32N2
Acta Crystallographica Section E (2005) 61, 7 o2277-o2279
a=14.1805(8)Å b=10.1822(5)Å c=18.3636(10)Å
α=90.00° β=91.0800(10)° γ=90.00°
5-(4-nitrophenyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline
C18H18N2O3
Acta Crystallographica Section E (2005) 61, 2 o461-o463
a=9.5001(10)Å b=9.8823(10)Å c=9.9403(10)Å
α=98.039(2)° β=115.157(2)° γ=104.092(2)°
Pyrimethaminium sulfosalicylate monohydrate
C12H14ClN4,C7H5O6S,H2O
Acta Crystallographica Section E (2005) 61, 5 o1480-o1482
a=15.2350(15)Å b=19.3290(12)Å c=15.8750(14)Å
α=90° β=113.960(6)° γ=90°
4-(4-nitrophenyl)-2,3,3a,4,5,9b-hexahydro furo[3,2-c]quinoline
C17H16N2O3
Acta Crystallographica Section E (2005) 61, 5 o1419-o1421
a=9.1090(10)Å b=9.2626(10)Å c=9.7553(11)Å
α=103.411(2)° β=102.791(2)° γ=107.081(2)°
1-[2-(2-hydroxyethoxy)ethyl]-4-(dibenzo[b,f][1,4]thiazepin-11- yl)piperazinium hemifumarate
2(C21H26O2N3S),C4H2O42
Acta Crystallographica Section E (2005) 61, 10 o3245-o3248
a=11.9479(8)Å b=13.2197(9)Å c=13.9479(9)Å
α=90.00° β=92.3270(10)° γ=90.00°
4-[Bis(2-methyl-1H-indol-3-yl)methyl]-1-(4-methoxyphenyl)-3-phenylazetidin- 2-one
C35H31N3O2
Acta Crystallographica Section E (2005) 61, 10 o3386-o3388
a=11.9751(7)Å b=13.4815(8)Å c=17.2114(11)Å
α=90.00° β=91.9780(10)° γ=90.00°
Bis(L-glutamic acid) sulfate hemihydrate
2C5H10N1O41,SO42,0.5H2O
Acta Crystallographica Section E (2002) 58, 3 o272-o276
a=12.536(2)Å b=12.596(2)Å c=13.306(2)Å
α=79.090(10)° β=62.050(10)° γ=65.880(10)°
L-ornithine nitrate
C5H13N2O21,NO31
Acta Crystallographica Section E (2002) 58, 6 o646-o648
a=5.1944(6)Å b=7.8030(10)Å c=11.0500(10)Å
α=90.00° β=98.750(10)° γ=90.00°
Bis(L-aspartic acid) nitrate
C4H8NO41,NO31,C4H7NO4
Acta Crystallographica Section E (2002) 58, 12 o1372-o1374
a=5.5840(7)Å b=11.491(3)Å c=21.043(5)Å
α=90.00° β=90.00° γ=90.00°
DL-valinium perchlorate
C5H12NO21,ClO41
Acta Crystallographica Section E (2003) 59, 1 o28-o30
a=10.3005(6)Å b=13.0905(8)Å c=14.6105(9)Å
α=81.288(2)° β=88.4473(19)° γ=75.9648(19)°
N-{2,3-diphenyl-6-[(Z)-phenylmethylidene]- 2-azabicyclo[2.2.2]oct-5-ylidene}-aniline
C32H28N2
Acta Crystallographica Section E (2005) 61, 10 o3273-o3275
a=14.6209(13)Å b=9.5899(9)Å c=17.9541(16)Å
α=90.00° β=107.701(2)° γ=90.00°
16-[4-(3-Chloropropoxy)-3-methoxybenzylidene]-4-androstene-3,17-dione
C30H37Cl1O4
Acta Crystallographica Section E (2006) 62, 6 o2190-o2192
a=8.0046(4)Å b=17.4763(9)Å c=19.6133(10)Å
α=90.00° β=90.00° γ=90.00°
4-Chlorophenyl thiobenzoate
C13H9ClOS
Acta Crystallographica Section E (2005) 61, 2 o340-o342
a=5.8410(5)Å b=13.3630(11)Å c=15.3250(17)Å
α=90.00° β=90.00° γ=90.00°
15,18-dimethyl-5-dioxo-14- oxapentacyclo[11.4.1.0^2,15^.0^4,13^.0^6,11^]octadeca-3,6,8,10-tetraene- 18-carbaldehyde
C20H18O4
Acta Crystallographica Section E (2005) 61, 2 o494-o496
a=13.3078(19)Å b=7.9299(11)Å c=15.168(2)Å
α=90.00° β=90.00° γ=90.00°
Bis(L-proline) H + perchlorate
2C5H9NO2,H1.ClO41
Acta Crystallographica Section E (2002) 58, 1 o74-o76
a=7.848(6)Å b=7.3951(14)Å c=12.834(5)Å
α=90.00° β=90.95(4)° γ=90.00°
DL-valinium nitrate
C5H12NO21,NO31
Acta Crystallographica Section E (2002) 58, 2 o95-o97
a=9.5695(10)Å b=11.2104(16)Å c=17.537(3)Å
α=108.52(3)° β=104.14(2)° γ=90.25(2)°
Bis(L-tyrosinium)sulfate monohydrate
2C9H12NO31,O4S2,H2O
Acta Crystallographica Section E (2002) 58, 2 o211-o214
a=13.473(2)Å b=6.1340(10)Å c=13.785(3)Å
α=90.00° β=109.51(2)° γ=90.00°
L-phenylalanine L-phenylalanium dihydrogen phosphate
C9H11NO2,C9H12NO21,H2PO41
Acta Crystallographica Section E (2002) 58, 2 o123-o125
a=13.4410(10)Å b=4.8760(4)Å c=15.470(2)Å
α=90° β=97.120(10)° γ=90°
L-citrullinium perchlorate
C6H14N3O31,ClO41
Acta Crystallographica Section E (2002) 58, 10 o1177-o1179
a=5.11130(10)Å b=11.3497(2)Å c=19.3853(3)Å
α=90.00° β=90.00° γ=90.00°
DL-valinium dihydrogen phosphate
C5H12NO21,H2PO41
Acta Crystallographica Section E (2002) 58, 8 o879-o881
a=9.2010(10)Å b=10.0035(6)Å c=11.195(2)Å
α=90.00° β=113.730(10)° γ=90.00°
L-argininium chloride
C6H15N4O21,Cl1
Acta Crystallographica Section E (2002) 58, 7 o747-o749
a=5.1263(8)Å b=9.4610(10)Å c=10.322(2)Å
α=88.138(5)° β=76.447(4)° γ=89.745(5)°
Bis(L-proline) H+ nitrate
2C5H9NO2,H1,NO31
Acta Crystallographica Section E (2002) 58, 8 o862-o864
a=7.2006(6)Å b=7.7110(10)Å c=24.060(3)Å
α=90.00° β=90.00° γ=90.00°
L-methioninium nitrate
C5H12NO2S,NO3
Acta Crystallographica Section E (2002) 58, 8 o882-o884
a=10.682(2)Å b=5.577(2)Å c=16.829(6)Å
α=90.00° β=100.92(2)° γ=90.00°
Bis(β-alanine) hydrogen picrate
H,C6H2N3O7,2C3H7NO2
Acta Crystallographica Section E (2004) 60, 9 o1630-o1632
a=4.9515(4)Å b=11.725(2)Å c=14.931(2)Å
α=78.000(10)° β=83.750(10)° γ=82.450(10)°
L-valinium picrate
C5H12NO2,C6H2N3O7
Acta Crystallographica Section E (2004) 60, 9 o1530-o1532
a=9.9714(13)Å b=6.2930(5)Å c=12.6480(9)Å
α=90.000° β=110.500(10)° γ=90.000°
Bis(DL-methioninium) sulfate
2C5H12NO2S,SO42
Acta Crystallographica Section E (2004) 60, 10 o1691-o1693
a=10.233(5)Å b=10.233(5)Å c=44.494(5)Å
α=90.0° β=90.0° γ=120.0°
Scandenin
C26H26O6
Acta Crystallographica Section E (2005) 61, 3 o596-o598
a=18.1505(10)Å b=17.3369(10)Å c=14.5209(8)Å
α=90.00° β=95.0540(10)° γ=90.00°
1,4-dihydro-6-methy-5-N-methy carbamoyl-4-phenyl-2(3H)-pyrimidinethione
C13H15N3OS.C2H6OS
Acta Crystallographica Section E (2005) 61, 5 o1414-o1416
a=32.2080(19)Å b=6.8884(4)Å c=16.6204(10)Å
α=90.00° β=109.1560(10)° γ=90.00°
1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)- (4-hydroxyphenyl)azetidin-2-one monohydrate
C24H21F2NO3,H2O
Acta Crystallographica Section E (2005) 61, 9 o2907-o2909
a=6.2396(4)Å b=15.4657(10)Å c=22.3320(14)Å
α=90.00° β=90.00° γ=90.00°
1,4-Dihydro-6-methyl-5-(N-methylcarbamoyl)-4-(4-nitrophenyl)pyrimidine- 2(3H)-thione monohydrate
C13H14N4O3S,H2O
Acta Crystallographica Section E (2005) 61, 12 o4130-o4132
a=4.8373(5)Å b=9.8906(11)Å c=16.0930(17)Å
α=81.414(2)° β=84.968(2)° γ=86.248(2)°
6-[(Z)-Benzylidene]-2,3-diphenyl-2-azabicyclo[2.2.2]octan-5-one
C26H23NO
Acta Crystallographica Section E (2005) 61, 12 o4198-o4199
a=10.1554(9)Å b=16.5088(15)Å c=11.7903(11)Å
α=90.00° β=97.154(2)° γ=90.00°
T(3),t(5)-Dimethyl N-nitroso-r(2),c(6)-bis(o-chlorophenyl)piperidine-4-one oxime.
C19H19Cl2N3O2
Acta Crystallographica Section E (2005) 61, 12 o3987-o3989
a=7.9168(7)Å b=8.5941(8)Å c=14.1572(13)Å
α=90.225(2)° β=101.459(2)° γ=94.810(2)°
R-2,c-6-Bis(4-chlorophenyl)-t-3,t-5-dimethyl-1-nitrosopiperidin-4-one oxime
C19H19Cl2N3O2
Acta Crystallographica Section E (2005) 61, 12 o4345-o4347
a=12.3909(9)Å b=11.1670(8)Å c=14.1980(10)Å
α=90.00° β=100.9910(10)° γ=90.00°
Kynathrin cinnamic acid
C6H9N3,2C9H8O2
Acta Crystallographica, Section E (2005) 61, 1 o4203-o4205
a=32.045(2)Å b=8.7676(7)Å c=15.9796(10)Å
α=90° β=90° γ=90°
3,t-6-Dihydroxy-t-5-methoxycarbonyl-c-6-methyl-r-4-phenyl-4,5,6,7-tetrahydro- 1H-indazole
C16H18N2O4
Acta Crystallographica Section E (2006) 62, 2 o656-o658
a=9.3871(4)Å b=14.7295(6)Å c=21.6478(9)Å
α=90.00° β=90.00° γ=90.00°
3-Amino-1-(4-nitrobenzyl)pyridinium bromide
C12H12O2N3,Br
Acta Crystallographica Section E (2006) 62, 2 o482-o484
a=7.6440(5)Å b=14.1397(10)Å c=23.7588(16)Å
α=90.00° β=90.00° γ=90.00°
17-allyl-16,17a-dioxo-17-aza-D-homoestra-1,3,5(10)-trien-3-ol
C21H25NO3
Acta Crystallographica Section E (2006) 62, 2 o653-o655
a=7.8071(8)Å b=12.0975(12)Å c=18.3120(19)Å
α=90.00° β=90.00° γ=90.00°
Ethyl (E)-2-benzoyl-3-phenylpropenoate
C18H16O3
Acta Crystallographica Section E (2006) 62, 2 o708-o710
a=10.8099(8)Å b=7.2746(5)Å c=18.5285(13)Å
α=90.00° β=94.3260(10)° γ=90.00°
16-Cyano-13α-(5-methyl-1,3,4-oxadiazol-2-yl)-13,16-seco-17-nor- androst-4-en-3-one
C21H27N3O2
Acta Crystallographica Section E (2006) 62, 3 o1019-o1021
a=6.0831(11)Å b=7.6736(14)Å c=20.614(4)Å
α=90.00° β=95.796(3)° γ=90.00°
4-amino-6-tert-butyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H)-one
C7H12N4OS
Acta Crystallographica Section E (2006) 62, 4 o1382-o1383
a=12.5196(8)Å b=6.9535(4)Å c=12.5987(8)Å
α=90.00° β=112.0390(10)° γ=90.00°
Bis(D-phenylglycinium)sulfate monohydrate
2C8H10NO21,SO42,H2O
Acta Crystallographica Section E (2001) 57, 8 o754-o756
a=12.3201(12)Å b=5.9377(15)Å c=14.2908(16)Å
α=90.000(14)° β=111.369(10)° γ=90.000(13)°
Hydrogen bis[L-lysinium(2+)] dichloride perchlorate
C6H15N2O21,C6H16N2O22,ClO4,2Cl
Acta Crystallographica Section E (2001) 57, 9 o875-o877
a=5.0264(6)Å b=20.822(2)Å c=20.897(2)Å
α=90.00° β=90.00° γ=90.00°
Bis(DL-phenylalaninium)sulfate monohydrate
2C9H12NO21,O4S2,H2O
Acta Crystallographica Section E (2001) 57, 8 o772-o774
a=14.560(2)Å b=6.6000(12)Å c=22.115(4)Å
α=90.00° β=90.70(2)° γ=90.00°
L-Argininium dinitrate
C6H16N4O22,2NO31
Acta Crystallographica Section E (2001) 57, 9 o872-o874
a=7.744(5)Å b=7.284(5)Å c=11.653(5)Å
α=90.00° β=92.600(5)° γ=90.00°
D-serinium D-serine nitrate
C3H8NO31,NO31,C3H7NO3
Acta Crystallographica Section E (2001) 57, 8 o682-o684
a=5.9290(10)Å b=8.195(7)Å c=11.503(2)Å
α=90.00° β=100.060(10)° γ=90.00°
Bis(L-histidinium sulfate) trihydrate
2C6H11N3O22,2S1O42,3H2O
Acta Crystallographica Section E (2001) 57, 7 o607-o609
a=8.3400(13)Å b=8.9291(11)Å c=10.724(2)Å
α=102.576(13)° β=107.704(15)° γ=119.667(11)°
Bis(L-threoninium)sulfate monohydrate
2C4H10NO31,SO42,H2O
Acta Crystallographica Section E (2001) 57, 7 o581-o583
a=23.096(4)Å b=6.281(9)Å c=11.6480(10)Å
α=90.00° β=116.122(9)° γ=90.00°
Bis(DL-aspartic acid) sulfate
2C4H8NO41,SO42
Acta Crystallographica Section E (2001) 57, 8 o679-o681
a=16.774(4)Å b=5.9697(9)Å c=14.5276(18)Å
α=90.00° β=98.66(2)° γ=90.00°
Bis( L-Lysinium(+)) hydrogen dichloride nitrate
2C6H15N2O21,H1,NO31,2Cl1
Acta Crystallographica Section E (2001) 57, 9 o888-o890
a=4.9846(2)Å b=20.604(2)Å c=20.663(2)Å
α=90.00° β=90.00° γ=90.00°
DL-phenylalaninium dihydrogen phosphate
C9H12NO21,H2PO41
Acta Crystallographica Section E (2001) 57, 11 o1078-o1080
a=13.899(7)Å b=9.956(8)Å c=9.051(2)Å
α=90.00° β=108.726(8)° γ=90.00°
Bis(β-Alanine) H+ nitrate
2C3H7NO2,H1,NO31
Acta Crystallographica Section E (2001) 57, 11 o1004-o1006
a=19.7910(10)Å b=5.3220(3)Å c=10.9740(10)Å
α=90.00° β=113.923(6)° γ=90.00°
D-phenylglycinium perchlorate
C8H10NO2.ClO4
Acta Crystallographica Section E (2001) 57, 12 o1149-o1151
a=5.4510(10)Å b=8.807(2)Å c=22.649(5)Å
α=90.00° β=90.00° γ=90.00°
L-Phenylalanine--nitric acid (2/1)
2C9H11NO2,H1,NO31
Acta Crystallographica Section E (2001) 57, 10 o916-o918
a=12.536(16)Å b=5.378(4)Å c=14.962(9)Å
α=90.00° β=107.83(8)° γ=90.00°
Β-alaninium perchlorate
C3H8NO21,ClO41
Acta Crystallographica Section E (2001) 57, 11 o1130-o1132
a=7.024(3)Å b=7.556(4)Å c=14.102(4)Å
α=90.00° β=97.52(4)° γ=90.00°
Bis(L-ornithinium) chloride nitrate sulfate
2C5H14N2O22,Cl1,NO31,SO42
Acta Crystallographica Section E (2004) 60, 5 o768-o770
a=13.872(5)Å b=9.578(6)Å c=9.1780(10)Å
α=90.00° β=125.350(14)° γ=90.00°
Olanzapinium nicotinate
C17H21N4S,C6H4NO2
Acta Crystallographica Section E (2005) 61, 8 o2720-o2723
a=9.2565(10)Å b=11.2224(12)Å c=12.0629(13)Å
α=63.164(2)° β=87.485(2)° γ=83.735(2)°
4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-hydroxy-1-[2-(2-methyl-4-oxo-3,4,6,7,8,9- hexahydro-2H-pyrido[1,2-a]pyrimidin-3-yl)ethyl]piperidine N-oxide
C23H27FN4O3,H2O2,CH4O
Acta Crystallographica Section E (2005) 61, 8 o2515-o2517
a=37.007(4)Å b=7.7558(8)Å c=17.214(2)Å
α=90.00° β=105.503(2)° γ=90.00°
Tri(L-Isoleucinium) sulfate bisulfate
3C6H14NO2,H1S1O4,S1O42
Acta Crystallographica Section E (2001) 57, 6 o558-o560
a=6.743(5)Å b=19.418(5)Å c=22.095(5)Å
α=90° β=90° γ=90°
L-Valine L-Valinium Perchlorate
C5H11NO2,ClO4,C5H12NO2,H2O
Acta Crystallographica Section E (2001) 57, 5 o466-o468
a=11.235(3)Å b=5.8312(14)Å c=13.0948(19)Å
α=90.00° β=91.282(16)° γ=90.00°
Bis(DL-Methioninium)sulfate
2C5H12NO2S1,SO42
Acta Crystallographica Section E (2001) 57, 8 o746-o748
a=10.281(3)Å b=10.281(3)Å c=14.788(6)Å
α=90.00° β=90.00° γ=120.00°
2-Amino-1-(4-nitrobenzyl)pyridinium bromide
C12H12O2N3,Br
Acta Crystallographica Section E (2006) 62, 1 o74-o76
a=8.0505(6)Å b=14.0971(10)Å c=21.8990(15)Å
α=90.00° β=90.00° γ=90.00°
N-{3-(4-Chlorophenyl)-6-[(Z)-(4-chlorophenyl)methylidene]-2-phenyl- 2-azabicyclo[2.2.2]oct-5-ylidene}aniline
C32H26Cl2N2
Acta Crystallographica Section E (2006) 62, 1 o318-o320
a=14.3560(6)Å b=10.0621(4)Å c=18.3872(8)Å
α=90.00° β=91.4270(10)° γ=90.00°
(Z)-[2-(1-Methyl-1H-indol-3-yl)methylidene]cyclohexanone
C16H17NO
Acta Crystallographica Section E (2005) 61, 11 o3672-o3673
a=7.9154(9)Å b=13.7376(14)Å c=22.980(3)Å
α=90.00° β=90.00° γ=90.00°
Lamotrigine benzoate dimethylformamide solvate
C9H8N5Cl2,C7H5O2,C3H7NO
Acta Crystallographica Section E (2005) 61, 11 o3805-o3807
a=8.9585(13)Å b=10.5522(15)Å c=12.3183(18)Å
α=79.442(2)° β=78.703(2)° γ=71.864(2)°
L-methionine L-methioninium perchlorate monohydrate
C5H12NO2S1,ClO41,C5H11NO2S,H2O
Acta Crystallographica Section E (2002) 58, 7 o779-o781
a=11.3720(15)Å b=5.5876(8)Å c=15.323(2)Å
α=90.00° β=107.782(5)° γ=90.00°
DL-phenylalaninium nitrate
C9H12NO2,NO3
Acta Crystallographica Section E (2002) 58, 10 o1103-o1105
a=12.005(7)Å b=5.758(2)Å c=16.250(9)Å
α=90.00° β=107.48(6)° γ=90.00°
DL-threoninium dihydrogen phosphate
C4H10NO31,H2PO41
Acta Crystallographica Section E (2002) 58, 11 o1185-o1187
a=9.0590(6)Å b=19.507(3)Å c=10.1015(9)Å
α=90.00° β=90.00° γ=90.00°
L-aspartic acid monohydrate
C4H7NO4,H2O
Acta Crystallographica Section E (2003) 59, 7 o1073-o1075
a=5.587(4)Å b=9.822(5)Å c=11.813(9)Å
α=90.00° β=90.00° γ=90.00°
3-[2-Methoxy-5-(1-phenylethyl)phenyl]-2,5-diphenyl tetrahydro-4-isoxazolyl(2-thienyl)methanone
C36H33N1O3S1
Acta Crystallographica Section E (2004) 60, 12 o2503-o2505
a=19.712(3)Å b=9.823(3)Å c=15.805(2)Å
α=90.00° β=90.00° γ=90.00°
6,10-bis(acetyloxy)-8-isopropyl-4,4,11a-trimethyl-2-oxo-2,3,4,6,11,11a- hexahydrobenzo[5,6]cyclohepta[1,2-b]pyran-9-yl acetate
C26H32O8
Acta Crystallographica Section E (2005) 61, 2 o380-o382
a=10.4278(5)Å b=13.3828(6)Å c=18.0857(9)Å
α=90.00° β=90.00° γ=90.00°
7-chloro-8-fluoro-4-phenyl-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline
C17H15ClFNO
Acta Crystallographica Section E (2005) 61, 1 o102-o104
a=25.826(2)Å b=6.8065(6)Å c=17.2924(16)Å
α=90° β=102.490(2)° γ=90°
4-(4-chlorophenyl)-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline
C17H16ClNO
Acta Crystallographica Section E (2005) 61, 1 o195-o197
a=14.1068(9)Å b=9.5526(6)Å c=21.1298(13)Å
α=90.00° β=90.00° γ=90.00°
Bharangin triacetate
C26H32O8
Acta Crystallographica Section E (2005) 61, 3 o687-o689
a=8.1986(5)Å b=14.0252(9)Å c=23.4820(10)Å
α=90.00° β=90.00° γ=90.00°
Methyl 6α-hydroxy-3,13-clerodadien-15,16-olid-18-oate
C21H30O5
Acta Crystallographica Section E (2005) 61, 4 o854-o856
a=10.3572(5)Å b=11.6812(5)Å c=15.5784(7)Å
α=90.00° β=90.00° γ=90.00°
1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)prop- 2-en-1-one
C21H22O4
Acta Crystallographica Section E (2005) 61, 4 o1020-o1022
a=7.5025(5)Å b=22.5080(15)Å c=11.1960(7)Å
α=90.00° β=101.6390(10)° γ=90.00°